Please use this identifier to cite or link to this item: https://doi.org/10.1038/cgt.2010.32
DC FieldValue
dc.titleBaculovirus-transduced bone marrow mesenchymal stem cells for systemic cancer therapy
dc.contributor.authorBak, X.Y.
dc.contributor.authorYang, J.
dc.contributor.authorWang, S.
dc.date.accessioned2014-10-27T08:22:35Z
dc.date.available2014-10-27T08:22:35Z
dc.date.issued2010-10-11
dc.identifier.citationBak, X.Y., Yang, J., Wang, S. (2010-10-11). Baculovirus-transduced bone marrow mesenchymal stem cells for systemic cancer therapy. Cancer Gene Therapy 17 (10) : 721-729. ScholarBank@NUS Repository. https://doi.org/10.1038/cgt.2010.32
dc.identifier.issn09291903
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/100147
dc.description.abstractAdult stem cells may serve as powerful cellular vehicles to deliver therapeutic genes for cancer therapy. In such applications, effective and safe transduction to load stem cells with genes of interest is essential. To examine whether baculovirus can be used to fulfill this task, we tested a range of baculoviral vectors in human bone marrow mesenchymal stem cells (MSCs). A vector using the human cytomegalovirus immediate-early gene promoter to drive transgene expression and the woodchuck hepatitis virus posttranscriptional regulatory element to enhance translation was able to transduce MSCs with efficiency close to 80%. Following the observation that baculoviral transduction did not significantly affect surface marker expression of the stem cells, we tested the feasibility of using baculovirus-transduced MSCs for targeted cancer therapy. We transduced cells with a baculoviral vector harboring the herpes simplex virus thymidine kinase gene, and performed tail vein injection of the transduced cells into mice preinoculated subcutaneously with human U87 glioma cells. After ganciclovir prodrug injection, we observed inhibition of tumor growth and significantly prolonged survival of tumor-inoculated animals. Our findings suggest that baculoviral transduction of MSCs is an attractive option to generate targeting vehicles for systemic cancer therapy. © 2010 Nature America Inc. All rights reserved.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1038/cgt.2010.32
dc.sourceScopus
dc.subjectbaculoviurs
dc.subjectglioma
dc.subjectmesenchymal stem cells
dc.subjectsuicide gene therapy
dc.typeArticle
dc.contributor.departmentBIOLOGICAL SCIENCES
dc.description.doi10.1038/cgt.2010.32
dc.description.sourcetitleCancer Gene Therapy
dc.description.volume17
dc.description.issue10
dc.description.page721-729
dc.description.codenCGTHE
dc.identifier.isiut000281910800006
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

38
checked on May 9, 2022

WEB OF SCIENCETM
Citations

32
checked on May 9, 2022

Page view(s)

179
checked on May 12, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.